From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen

Blood

Volumn 89, Issue 9, 1997, Pages 3077-3091

  Hadley, Terence J ^a   Peiper, Stephen C ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ANTIGEN DETECTION; BLOOD GROUP DUFFY SYSTEM; BLOOD TRANSFUSION; CELL ADHESION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIGAND BINDING; MALARIA; MOLECULAR BIOLOGY; PLASMODIUM VIVAX; PRIORITY JOURNAL; PURKINJE CELL; RETICULOCYTE; REVIEW; STRUCTURE ACTIVITY RELATION; VACCINE PRODUCTION;

EID: 0030917736     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3077     Document Type: Review

References (130)

1. Landsteiner K: Individual differences in human blood. Science 73:405, 1931
2. Levine P, Burnham L, Katzin EM, Vogel P: Role of iso-immunization in pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 42:925, 1941
3. Anstee DJ: Blood group-active surface molecules of the human red blood cell. Vox Sang 58:1, 1990
4. Issitt PD, Issitt CH: Applied Blood Group Serology. Miami, FL, Montgomery Scientific, 1985
5. Anstee DJ: Blood group antigens defined by the amino acid sequences of red cell surface proteins. Transf Med 5:1, 1995
6. Agre PC, Catron J-P (eds): Blood Group Antigens of the Human Red Cell. Structure, Function, and Clinical Significance. Baltimore, MD, Johns Hopkins University Press, 1992
7. Cartron, J-P, Rouger P (eds): Molecular Basis of Major Blood Group Antigens, Blood Cell Biochemistry, vol 8. New York, NY, Plenum, 1995
8. Telen MJ: Erythrocyte blood group antigens: Not so simple after all. Blood 85:299, 1995
9. Barnwell JW, Galinski MR: Plasmodium vivax: A glimpse into the unique and shared biology of the merozoite. Ann Trop Med Parasitol 89:113, 1995
10. Pogo AO, Chaudhuri A: Duffy and receptors for P. vivax and chemokine peptides. Transf Clin Biol 2:269, 1995
11. Horuk R, Peiper SC: The Duffy antigen receptor for chemokines, in Horuk R (ed): Chemoattractant Ligands and Their Receptors. New York, NY, CRC, 1996
12. Horuk R, Martin A, Hesselgesser J, Hadley T, Lu ZH, Wang ZX, Peiper SC: The Duffy antigen receptor for chemokines: Struc-tural analysis and expression in the brain. J Leukoc Biol 59:29, 1996
13. Cutbush M, Mollison PL, Parkin DM: A new human blood group. Nature 165:188, 1950
14. b. Nature 168:1077, 1951
15. Chown B, Lewis M, Kaita H: The Duffy blood group in Caucasians: Evidence for a new allele. Am J Hum Genet 17:384, 1965
16. Lewis M, Kaita H, Chown B: The Duffy blood group system in Caucasians: A further population sample. Vox Sang 23:523, 1972
17. Mourant AE, Kopec AC, Domaniewska-Sobczak K: The Distribution of Human Blood Groups and Other Polymorphisms (ed 2). London, UK, Oxford University Press, 1976
18. Sanger R, Race RR, Jack J: The Duffy blood groups of New York Negroes: The phenotype Fy(a-b-). Br J Haematol 1:370, 1955
19. a preceding anti-Fy3 or -Fy5: A study of five cases. Transfusion Abstracts S150, 1985 (suppl)
20. a in five black Fy(a-b-) patients. Vox Sang 52:246, 1987
21. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo O: The coding sequence of Duffy blood group gene in humans and simians: Restriction fragment length polymorphism, antibody and malarial parasite specificities and expression in nonerythroid tissues in Duffy negative individuals. Blood 85:615, 1995
22. Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogborne K, Hadley TJ, Lu ZH, Hesselgesser J, Horuk R: The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 181:1311, 1995
23. Morion JA: Some observations on the action of blood-group antibodies on red cells treated with proteolytic enzymes. Br J Haematol 8:134, 1962
24. Judson PA, Anstee DJ: Comparative effect of trypsin and chymotrypsin on blood group antigens. Med Lab Sci 34:1, 1977
25. Albrey JA, Vincent EE Jr, Hutchinson J, Marsh WL, Allen FH, Gavin J, Sanger R: A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sang 20:29, 1971
26. Behzad O, Lee CL, Gavin J, Marsh WL: A new anti-erythrocyte antibody in the Duffy system: Anti-Fy4. Vox Sang 24:337, 1973
27. Colledge KI, Pezzulich M, Marsh WL: Anti-Fy5: An antibody disclosing a probable association between the Rhesus and Duffy glood group genes. Vox Sang 24:193, 1973
28. Moore S, Woodrow CF, McClelland DB: Isolation of membrane components associated with human red cell antigens Rh(D), (c), (E) and Fy. Nature 295:529, 1982
29. a antigen. Science 223:597, 1984
30. Tanner MJ, Anstee DJ, Mallison G, Ridgewell K, Martin PG, Avent ND, Parsons SF: Effect of endoglycosidase F-peptidyl N-glycosidase F preparations on the surface components of the human erythrocyte. Carbohydrate Res 178:203, 1988
31. Chaudhuri A, Pogo OA: The Duffy is a glycoprotein, in Cartron J-P, Rouger P (eds): Molecular Basis of Major Human Blood Group Antigens, Blood Cell Biochemistry, vol 8. New York, NY, Plenum, 1995
32. Wasniowska K, Eichenberger P, Kugele F, Hadley TJ: Purification of a 28 kD non-aggregating tryptic peptide of the Duffy blood group protein. Biochem Biophys Res Commun 192:366, 1993
33. Wasniowska K, Hadley TJ: The Duffy blood group antigen: An update. Transf Med Rev 8:281, 1994
34. Nichols ME, Rubinstein P, Barnwell J, Rodriguez de Cordoba S, Rosenfield RE: A new human Duffy blood group specificity defined by a murine monoclonal antibody, Immunogenetics and association with susceptibility to Plasmodium vivax. J Exp Med 166:776, 1987
35. Barnwell JW, Nichols ME, Rubenstein P: In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med 169:162, 1989
36. Riwom S, Janvier D, Navenot JM, Benbunan M, Muller JY, Blanchard D: Production of a new murine monoclonal antibody with Fy6 spcificity and characterization of the immunopurified N-glycosylated Duffy-active molecule. Vox Sang 66:61, 1994
37. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK: Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189:561, 1975
38. Mason SJ, Miller LH, Shiroishi T, Dvorak JA, McGinniss MH: The Duffy blood group determinants: Their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria. Br J Haematol 36:327, 1977
39. Miller LH, Aikawa M, Johnson JG, Shiroishi T: Interaction between cytochalasin B-treated malarial parasites and erythrocytes. Attachment and junction formation. J Exp Med 149:172, 1979
40. Aikawa M, Miller LH, Johnson J, Rabbege J: Erythrocyte entry by malarial parasites: A moving junction between erythrocyte and parasite. J Cell Biol 77:72, 1978
41. Young MD, Eyles DE, Burgess RW, Jeffrey GM: Experimental testing of the immunity of Negroes to Plasmodium vivax. J Parasitol 41:315, 1955
42. Miller LH, Mason SJ, Clyde DF, McGinniss MH: The resistance factor to Plsmodium vivax in blacks: The Duffy blood group genotype, FyFy. N Engl J Med 295:302, 1976
43. Miller LH, McGinniss MH, Holland PV, Sigmon P: The Duffy blood group phenotype in American blacks with Plasmodium Vivax in Vietnam. Am J Trop Med Hyg 27:1069, 1978
44. Spencer HC, Miller LH, Collins WE, Knud-Hansen C, McGinnis MH, Shiroishi T, Lobos RA, Feldman RA: The Duffy blood group and resistance to Plasmodium vivax in Honduras. Am J Trop Med Hyg 27:664, 1978
45. Kitchen SF: The infection of reticulocytes by Plasmodium vivax. Am J Trop Med 18:347, 1938
46. Galinski MR, Medina CC, Ingravallo P, Barnwell JW: A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 69:1213, 1992
47. Haynes JD, Dalton JP, Klotz FW, McGinnis MH, Hadley TJ, Hudson DE, Miller LH: Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J Exp Med 167:1873, 1988
48. Wertheimer SP, Barnwell JW: Plasmodium vivax interaction with the human Duffy blood group glycoprotein: Identification of a parasite receptor-like protein. Exp Parasitol 69:340, 1989
49. Sim BKL, Chitnis CE, Wasniowska K, Hadley TJ, Miller LH: Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum malaria. Science 264:1941, 1994
50. Adams JH, Sim BK, Dolan SA, Fang X, Kaslow DC, Miller LH: A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA 89:7085, 1992
51. Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, Aikawa M, Miller LH: The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive Malaria merozoites. Cell 63:141, 1990
52. Fang XD, Kaslow DC, Adams JH, Miller LH: Cloning of the Plasmodium vivax Duffy receptor. Mol Biochem Parasitol 44:125, 1992
53. Chitnis CE, Miller LH: Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med 180:497, 1994
54. Chitnis CE, Chaudhuri A, Horuk R, Pogo O, Miller LH: The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythroytes. J Exp Med 184:1531, 1996
55. Peterson DS, Miller LH, Wellems TE: Isolation of multiple sequences from the Plasmodium falciparum genome that encode conserved domains homologous to those in erythrocyte-binding proteins. Proc Nati Acad Sci USA 92:7100, 1995
56. Su XZ, Heatwole VM, Wertheimer SP, Guinet F, Herrfeldt JA, Peterson DS, Ravetch JA, Wellems TE. The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell 82:89, 1995
57. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, Pinches R, Newbold CI, Miller LH: Switches in expression of Plamodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82:101, 1995
58. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, Taraschi TF, Howard RJ: Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82:77, 1995
59. Leech JH, Barnwell JW, Miller LH, Howard RJ: Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes. J Exp Med 159:1567, 1984
60. Howard RJ, Barnwell JW, Rock EP, Neequaye J, Ofori-Adjei D, Maloy WL, Lyon JA, Saul A: Two approximately 300 kilodalton Plasmodium falciparum proteins at the surface membrane of infected erythrocytes. Mol Biochem Parasitol 27:207, 1988
61. van Shravendijk MR, Rock EP, Marsh K, Ito Y, Aikawa M, Neequaye J, Ofori-Adjei D, Rodriquez R, Patarroyo ME, Howard RJ: Characterization and localization of Plasmodium falciparum surface antigens on inficated erythrocytes from West Africa. Blood 78:226. 1991
62. Udeinya IJ, Schmidt JA, Aikawa M, Miller LH, Green I: Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells Science 213:555, 1981
63. Pasloske BL, Howard RJ: Malaria, the red celi and the endothelium. Annu Rev Med 45:283, 1994
64. Raventos-Suarez C, Kaul DK, Macaluso F, Nagel RL: Membrane knobs are required for the microcirculatory obstruction induced by Plasmodium falciparum-infected erythrocytes. Proc Natl Acad Sci USA 82:3829, 1985
65. Pongponratn E, Riganti M, Punpoowong B, Aikawa M: Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: A pathologic study. Am J Trop Med Hyg 44:168, 1991
66. Luse SA, Miller LH: Plasmodium falciparum malaria: Ultra-structure of parasitized erythrocytes in cardiac vessels. Am J Trop Med Hyg 20:655, 1971
67. Langreth SG, Peterson E: Pathogenicity, stability and immunogenicity of a knobless clone of Plasmodium falciparum in Columbian owl monkeys. Infect Immun 47:760, 1985
68. Oster CN, Koontz LC, Wyler DJ: Malaria in asplenic mice: Effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg 29:1138, 1980
69. Howard RJ, Gilladoga AD: Molecular studies related to the pathogenesis of cerebral malaria. Blood 74:2603, 1989
70. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD: Parasite sequestration in Plasmodium falciparum malaria: Spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Nail Acad Sci USA 80:5075, 1983
71. Udeinya IJ, Miller LH, McGregor IA, Jensen JB: Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature 303:429, 1983
72. Marsh K, Howard RJ: Antigens induced on erythrocytes by P. falciparum: Expression of diverse and conserved determinants. Science 231:150 1986
73. Magowan C, Wollish W, Anderson L, Leech J: Cytoadherence by Plasmodium falciparum-infected erythrocytes is correlated with the expression of a family of variable proteins on infected erythrocytes. J Exp Med 168:1307, 1988
74. Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, Marsh K, Newbold Cl: Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357:689, 1992
75. Biggs BP, Anders RF, Dillon HE, Davern KM, Martin M, Peterson C, Brown GV: Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. J Immunol 149:2047, 1992
76. Ockenhouse CF, Ho M, Tandon NN, Van Seventer GA, Shaw S, White NJ, Jamieson GA, Chulay JD, Webster HK: Molecular basis of sequestration in severe and uncomplicated Plasmodium falcipanim malaria: Differential adhesion of infected erythrocytes to CD36 and ICAM-I. J Infect Dis 164:163, 1991
77. Ockenhouse CF, Tegoshi T, Maeno Y, Benjamin C, Ho M, Kan KE, Thway Y, Win K Aikawa M, Lobb RR: Human vascular endothelial cell adhesion receptors for Plasmodium-infected erythrocytes: Roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 176:1183, 1992
78. Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ, Howard RJ, Dixit VM, Frazier WA, Miller LH, Ginsburg V: Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 318:64, 1985
79. Miller LH, Good MF, Milon G: Malaria pathogenesis. Science 264:1878, 1994
80. Dolan SA, Miller LH, Wellems TE: Evidence for a switching mechanism in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest 86:618, 1990
81. Tsuboi T, Kappe SH, al-Yaman F, Prickelt MD, Alpers M, Adams JH: Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding protein. Infect Immun 62:5581, 1994
82. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617, 1991
83. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97, 1994
84. Schall T: The chemokines, in Thomson AW (ed): The Cytokine Handbook (ed 2). New York, NY, Academic, 1994, p 419
85. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 3:165, 1991
86. Keiner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Ziotnik A: Lymphotactin: A cytokine that represents a new class of chemokine. Science 266:1395, 1994
87. Murphy PM: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593, 1994
88. Horuk R: Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 15:159, 1994
89. Horuk R: Cytokine receptors, in Peroutka SJ (ed): Handbook of Receptors and Channels: G Protein-Coupled Receptors. Boca Raton, FL, CRC, 1993, p 87
90. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415, 1993
91. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 253:1278, 1991
92. Hebert CA, Chuntharapai A, Smith M, Colby T, Kim J, Horuk R: Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J Biol Chem 268:18549, 1993
93. Darbonne WC, Rice GC, Mohler MA, Apple T, Hegert CA, Valente AJ, Baker JB: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 88:1362, 1991
94. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 268:12247, 1993
95. Horuk R, Colby TJ, Darbonne WC, Schall TJ, Neote K: The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a bind-ing assay for the soluble receptor. Biochemistry 32:5733, 1993
96. Szabo MC, Soo KS, Ziotnik A, Schall TJ: Chemokine class differences in binding to the Duffy antigen/erythrocyte receptor. J Biol Chem 270:25348, 1995
97. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH: A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 261:1182, 1993
98. Hesselgesser J, Chitnis CE, Miller LH, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth C, Gillece-Castro BL, Horuk R: A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria. J Biol Chem 270:11472, 1995
99. Chaudhuri A, Zbrzezna V, Polykova J, Pogo AO, Hesselgesser J, Horuk R: Expression of the Duffy antigen in K562 cells Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 269:7835, 1994
100. Neote K, Mak JY, Kolakowski LF, Schall TJ: Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor. Blood 84:44, 1994
101. Hadley TJ, Lu Z-h, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J, Horuk R: Postcapillary venule endothelial cells in kidney express a multispecfic chemokine receptor that is structurally and functionally identical to the erythroid isoform which is the Duffy blood group antigen. J Clin Invest 94:985, 1994
102. 101a. Guo H, Slone S, Fingar V, Blanchard D, Peiper S, Hadley T: Tissue distribution and upregulation by inflammation. Blood 88:513a, 1996 (abstr, suppl 1)
103. Rot A: Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol Today 13:291, 1992
104. Hechtman DH, Cybulsky MI, Fuchs HJ, Baker JB, Gimbrone MA: Intravascular IL-8: Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol 147:883, 1991
105. Lawrence LB, Springer TA: Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 65:859, 1991
106. Chaudhuri A, Polyakova J, Zbrezna V, Williams K, Gulati S, Pogo AO: Cloning of glycoprotein D cDNA which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 90:10793, 1993
107. Chaudhuri A, Zbrzezna V, Johnson C, Nichols M, Rubinstein P, Marsh WL, Pogo AO: Purification and characterization of an erythrocyte membrane protein complex carrying Duffy blood group antigenicity. Possible receptor for plasmodium vivax and plasmodium Knowlesi malaria parasite. J Biol Chem 264:13770, 1989
108. Jacobs PA, Brunton M, Fackiewicz A, Newton M, Cook PJ, Robson EB: Studies on a family with three cytogenetic markers. Ann Hum Genet 33:325, 1970
109. Mathew S, Chaudhuri A, Murty VV, Pogo AO: Confirmation of Duffy blood group antigen locus (FY) at Iq22 → q23 by flourescence in situ hybridization. Cytogenet Cell Genet 67:68, 1994
110. Eisenberg D: Three-dimensional structure of membrane and surface proteins. Annu Rev Biochem 53:595, 1984
111. Tournamille C, Colin Y, Cartron JP, Le Van Kim C: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature Genet 10:224, 1995
112. Iwamoto S, Li J, Omi T, Ikemoto S, Kajii E: Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary endothelium. Blood 87:378, 1996
113. Iwamoto S, Li J, Sugimoto N, Okuda H, Kajii E: Characterization of the Duffy gene promoter: Evidence for tissue specific abolishment of expression in Fy(a-b-) of black individuals. Biochem Biophys Res Commun 222:852, 1996
114. h antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 90:823, 1995
115. b alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85:662, 1995
116. Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y: Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism. Hum Genet 95:407, 1995
117. Lu Z-h, Wang Z-x, Horuk R, Hesselgesser J, Lou YC, Hadley TJ, Peiper SC: The promiscuous chemokine binding profile of the Duffy antigen/recptor for chemokines (DARC) is primarily localized to sequences in the amino terminal domain. J Biol Chem 270:26239, 1995
118. Tournamille C, Le Van Kim C, Gane P, Proudfoot A, Cartron JP, Colin Y: Epitopes of the erythrocyte receptor for chemokines (Duffy glycoprotein) involved in IL8 binding (abstr). Trans Clin Biol 3:54s, 1996 (suppl)
119. Hausman E, Dzik W, Blanchard D: The red cell chemokine receptor is distinct from the Fy6 epitope. Transfusion 36:421, 1996
120. Wasniowska K, Blanchard D, Jauvier D, Wang ZX, Peiper SC, Hadley TJ, Lisowska E: Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines, Mol Immunol 33:917, 1996
121. Rothwell NJ, Hardwick AJ, Lindley I: Central actions of interleukin-8 in the rat are independent of prostaglandins. Horm Metab Res 22:595, 1990
122. Araujo DM, Cotman CW: Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors. Brain Res 600:49, 1993
123. Van Meir E, Ceska M, Effenberger F, Walz A, Grouzmann E, Desbaillets I, Frei K, Fontana A, de Tribolet N: lnterleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52:4297, 1992
124. Horuk R, Martin AW, Wang ZY, Schweitzer L, Gerassimides A. Guo H, Lu ZH, Hesselgesser J, Ferez HD, Kim J, Parker J, Hadley TJ, Peiper SC: Expression of chemokine receptors by subset of neurons in the central nervous system. J Immunol 158:2882, 1997
125. Horuk R, Wang ZX, Peiper SC, Hesselgesser J: Identification and characterization of a promiscuous chemokine binding protein in a human erythroleukemia cell line. J Biol Chem 269:17730, 1994
126. Klein PS, Sun TJ, Saxe CL, Kimmel AR, Johnson RL, Devreotes PN: A chemoattractant receptor controls development in Dictyostelium discoideum. Science 241:1467, 1988
127. Hart AC, Kramer H, Van Vactor DL, Paidhungat M, Zipursky SL: Induction of cell fate in the Drosophila retina: The bride of sevenless protein is predicted to contain a large extracellular domain and seven transmembrane segments. Genes Dev 4:1835, 1990
128. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M. Liang Y, Chi H. Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Placentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Kommens JM, St George-Hyslop PH: Familial Alheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzhelmer's disease type 3 gene. Nature 376:775, 1995
129. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi, M.P., Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Pollinsky R J, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi, RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH: Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 375:754, 1995
130. Levitan D, Greenwald I: Facilitation of lin-12-mediated signalling be sel-12, a Caenorhabditis elegans S182 Alzheimer' s disease gene. Nature 377:351, 1995